Home›VideosSun Pharma Q2: Revenue Rises 12% YoY To Rs 16,199 Cr; EBITDA Increases 5% YoY To Rs 4,744 CrCNBC-TV1830 Oct 2026#2QWithCNBCTV18 | Sun Pharma Beats Estimates